Literature DB >> 3905613

Purification and characteristics of the streptococcal chemotactic factor inactivator.

D E Wexler, P P Cleary.   

Abstract

The biochemical and immunological characteristics of the chemotactic factor inactivator of group A streptococci (SCFI) were examined. SCFI was extracted from intact M+ bacteria by limited trypsin digestion and purified sequentially by ammonium sulfate fractionation, hydrophobic interaction chromatography, and anion-exchange chromatography. SCFI activity was associated with multiple species as indicated by gel permeation chromatography and DEAE high-pressure liquid chromatography analyses. Polyacrylamide gel electrophoresis of the column-purified protein also demonstrated a high degree of molecular heterogeneity, with most of the material in a 103,000 to 114,000 Mr cluster. SCFI activity was sensitive to destruction by several proteolytic enzymes, and polyclonal antiserum to SCFI was able to neutralize its antichemotactic activity. Two-dimensional immunoelectrophoresis of SCFI indicated that the various copurified species were immunologically cross-reactive and indicated a high degree of antigenic homogeneity within the preparation. Western blot analysis of crude detergent extracts of M+ bacteria identified a major antigenic species corresponding to 135,000 Mr and a less abundant species of 137,000 Mr. SCFI antiserum was not reactive with M protein, and therefore SCFI appeared to be a distinct molecule, despite its close association with the M+ phenotype.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3905613      PMCID: PMC261145          DOI: 10.1128/iai.50.3.757-764.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Chemical properties of streptococcal proteinase and its zymogen.

Authors:  T Y LIU; N P NEUMANN; S D ELLIOTT; S MOORE; W H STEIN
Journal:  J Biol Chem       Date:  1963-01       Impact factor: 5.157

2.  Inhibition of alternative complement pathway opsonization by group A streptococcal M protein.

Authors:  P K Peterson; D Schmeling; P P Cleary; B J Wilkinson; Y Kim; P G Quie
Journal:  J Infect Dis       Date:  1979-05       Impact factor: 5.226

3.  A procedure for rapid and sensitive staining of protein fractionated by polyacrylamide gel electrophoresis.

Authors:  A Chrambach; R A Reisfeld; M Wyckoff; J Zaccari
Journal:  Anal Biochem       Date:  1967-07       Impact factor: 3.365

4.  Crossed immunoelectrophoresis.

Authors:  P O Ganrot
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels.

Authors:  B R Oakley; D R Kirsch; N R Morris
Journal:  Anal Biochem       Date:  1980-07-01       Impact factor: 3.365

7.  Purification and characterization of group A streptococcal T-1 antigen.

Authors:  R H Johnson; K L Vosti
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

8.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

9.  Characterization of group A streptococcal T-12 protein purified by ion-exchange column chromatography.

Authors:  A Ludwicka; M Kłoczewiak
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

10.  Streptococcal M protein extracted by nonionic detergent. I. Properties of the antiphagocytic and type-specific molecules.

Authors:  V A Fischetti; E C Gotschlich; G Siviglia; J B Zabriskie
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

View more
  14 in total

1.  Virulent human strains of group G streptococci express a C5a peptidase enzyme similar to that produced by group A streptococci.

Authors:  P P Cleary; J Peterson; C Chen; C Nelson
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

Review 2.  Streptococcus adherence and colonization.

Authors:  Angela H Nobbs; Richard J Lamont; Howard F Jenkinson
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

3.  Regulation of virulence by environmental signals in group A streptococci: influence of osmolarity, temperature, gas exchange, and iron limitation on emm transcription.

Authors:  K S McIver; A S Heath; J R Scott
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

4.  Localization of the streptococcal C5a peptidase to the surface of group A streptococci.

Authors:  S P O'Connor; P P Cleary
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

5.  Differential expression of genes in the vir regulon of Streptococcus pyogenes is controlled by transcription termination.

Authors:  K H Pritchard; P P Cleary
Journal:  Mol Gen Genet       Date:  1996-02-05

6.  Role of mga in growth phase regulation of virulence genes of the group A streptococcus.

Authors:  K S McIver; J R Scott
Journal:  J Bacteriol       Date:  1997-08       Impact factor: 3.490

7.  Specific binding of the activator Mga to promoter sequences of the emm and scpA genes in the group A streptococcus.

Authors:  K S McIver; A S Heath; B D Green; J R Scott
Journal:  J Bacteriol       Date:  1995-11       Impact factor: 3.490

8.  The ScpC protease of Streptococcus pyogenes affects the outcome of sepsis in a murine model.

Authors:  Hong Sjölinder; Lena Lövkvist; Laura Plant; Jens Eriksson; Helena Aro; Allison Jones; Ann-Beth Jonsson
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

9.  Similarity between the group B and A streptococcal C5a peptidase genes.

Authors:  P P Cleary; J Handley; A N Suvorov; A Podbielski; P Ferrieri
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

10.  Streptococcal C5a peptidase is a highly specific endopeptidase.

Authors:  P P Cleary; U Prahbu; J B Dale; D E Wexler; J Handley
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.